Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Hairy Cell Leukemia Variant”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06311227
What this trial is testing

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Who this might be right for
Recurrent Hairy Cell LeukemiaRecurrent Hairy Cell Leukemia Variant
National Cancer Institute (NCI) 20
Early research (Phase 1)Active Not RecruitingNCT03805932
What this trial is testing

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Who this might be right for
Hairy Cell Leukemia
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT01841723
What this trial is testing

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

Who this might be right for
Hairy Cell LeukemiaHairy Cell Leukemia VariantRecurrent Hairy Cell Leukemia+1 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Looking for participantsNCT04815356
What this trial is testing

Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant

Who this might be right for
Hairy Cell LeukemiaHairy Cell Leukemia Variant
National Cancer Institute (NCI) 27